Takashige Abe

2.9k total citations
154 papers, 1.7k citations indexed

About

Takashige Abe is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Takashige Abe has authored 154 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Surgery, 61 papers in Pulmonary and Respiratory Medicine and 30 papers in Oncology. Recurrent topics in Takashige Abe's work include Bladder and Urothelial Cancer Treatments (48 papers), Urinary and Genital Oncology Studies (37 papers) and Surgical Simulation and Training (26 papers). Takashige Abe is often cited by papers focused on Bladder and Urothelial Cancer Treatments (48 papers), Urinary and Genital Oncology Studies (37 papers) and Surgical Simulation and Training (26 papers). Takashige Abe collaborates with scholars based in Japan, United Kingdom and United States. Takashige Abe's co-authors include Nobuo Shinohara, Katsuya Nonomura, Toru Harabayashi, Satoru Maruyama, Ataru Sazawa, Ryuji Matsumoto, Takahiro Osawa, Kamran Ahmed, Sachiyo Murai and Nicholas Raison and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Takashige Abe

139 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takashige Abe Japan 24 1.1k 550 289 267 210 154 1.7k
Jonas Schiffmann Germany 25 525 0.5× 1.5k 2.8× 412 1.4× 190 0.7× 202 1.0× 87 2.2k
Harras B. Zaid United States 19 738 0.7× 723 1.3× 246 0.9× 226 0.8× 273 1.3× 43 1.4k
Stephen E. Strup United States 24 536 0.5× 1.2k 2.2× 175 0.6× 258 1.0× 550 2.6× 92 1.9k
Clayton Lau United States 19 678 0.6× 497 0.9× 214 0.7× 359 1.3× 102 0.5× 80 1.2k
Laurent Bresler France 28 1.7k 1.5× 289 0.5× 366 1.3× 79 0.3× 87 0.4× 62 2.2k
Noboru Numao Japan 22 549 0.5× 824 1.5× 337 1.2× 155 0.6× 90 0.4× 133 1.5k
Sangeeta Desai India 21 590 0.5× 448 0.8× 456 1.6× 177 0.7× 216 1.0× 120 1.5k
Seyed Rasoul Zakavi Iran 22 488 0.4× 475 0.9× 312 1.1× 67 0.3× 84 0.4× 153 1.7k
Martin Andreas Røder Denmark 20 380 0.3× 1.1k 2.0× 303 1.0× 268 1.0× 195 0.9× 138 1.6k
Junichiro Ishioka Japan 19 443 0.4× 608 1.1× 205 0.7× 120 0.4× 109 0.5× 100 1.1k

Countries citing papers authored by Takashige Abe

Since Specialization
Citations

This map shows the geographic impact of Takashige Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashige Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashige Abe more than expected).

Fields of papers citing papers by Takashige Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashige Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashige Abe. The network helps show where Takashige Abe may publish in the future.

Co-authorship network of co-authors of Takashige Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Takashige Abe. A scholar is included among the top collaborators of Takashige Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashige Abe. Takashige Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsubara, Nobuaki, Takahiro Osawa, Takashige Abe, et al.. (2025). FGFR2/3 Gene Alterations and Clinical Outcomes in Advanced/Metastatic Urothelial Cancer in Japan: MONSTARSCREEN Database Study. Cancer Science. 116(5). 1424–1432.
2.
Sazuka, Tomokazu, Katsunori Tatsugami, Suguru Shirotake, et al.. (2025). Outcomes of Nivolumab‐Plus‐Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J‐ ENCORE Study. International Journal of Urology. 33(1). e70281–e70281.
3.
Kanno, Toru, Katsuhiro Ito, Yuki Kita, et al.. (2025). Impact of lymph node dissection during surgery on the efficacy of pembrolizumab in patients with metastatic urothelial carcinoma. International Journal of Urology. 32(5). 593–597. 1 indexed citations
7.
Hirose, Takayuki, Kiyohiko Hotta, Naotoshi Iwahara, & Takashige Abe. (2025). How Many Potential Candidates Are There for Clinical Kidney Xenotransplantation in Japan?. American Journal of Transplantation. 25(8). S371–S372.
8.
Abe, Takashige, Madoka Higuchi, Kiyohiko Hotta, et al.. (2024). Surgical skill analysis focused on tissue traction in laparoscopic wet lab training. Surgery Open Science. 21. 7–13.
9.
Kawai, Taketo, Hideyasu Matsuyama, Keita Kobayashi, et al.. (2024). Photodynamic diagnosis‐assisted transurethral resection of bladder tumor for high‐risk non‐muscle invasive bladder cancer improves intravesical recurrence‐free survival (BRIGHT study). International Journal of Urology. 31(8). 906–912. 5 indexed citations
10.
Fujima, Noriyuki, Rina Kimura, Keita Sakamoto, et al.. (2024). Enhancing the image quality of prostate diffusion-weighted imaging in patients with prostate cancer through model-based deep learning reconstruction. European Journal of Radiology Open. 13. 100588–100588. 4 indexed citations
11.
Kita, Yuki, Katsuhiro Ito, Takuto Hara, et al.. (2024). Real‐world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. International Journal of Urology. 31(5). 552–559. 13 indexed citations
12.
Fujima, Noriyuki, Masami Yoneyama, Ryuji Matsumoto, et al.. (2023). Clinical utility of single-shot echo-planar diffusion-weighted imaging using L1-regularized iterative sensitivity encoding in prostate MRI. Medicine. 102(17). e33639–e33639. 1 indexed citations
13.
Kameda, Hiraku, Aika Miya, Hiroshi Nomoto, et al.. (2023). Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and ipilimumab: A case report. Medicine. 102(51). e36664–e36664. 3 indexed citations
14.
Abe, Takashige, Kohichi Takada, Yasuhiro Hida, et al.. (2022). Metastatic neuroendocrine carcinoma of right adrenal gland successfully treated with laparoscopic adrenalectomy after multimodal therapy. IJU Case Reports. 5(6). 446–450. 2 indexed citations
15.
Matsumoto, Kazumasa, Makito Miyake, Nobutaka Nishimura, et al.. (2022). Real‐world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette‐Guérin failure in non‐muscle‐invasive bladder cancer. International Journal of Urology. 29(10). 1195–1203. 3 indexed citations
16.
Raison, Nicholas, Andrea Gavazzi, Takashige Abe, Kamran Ahmed, & Prokar Dasgupta. (2020). Virtually Competent: A Comparative Analysis of Virtual Reality and Dry-Lab Robotic Simulation Training. Journal of Endourology. 34(3). 379–384. 16 indexed citations
17.
Kikuchi, Hiroshi, Takashige Abe, Ryuji Matsumoto, et al.. (2019). 腫瘍増殖活性INT1明細胞腎細胞癌と相関する腎臓測定スコア【JST・京大機械翻訳】. Urologic Oncology Seminars and Original Investigations. 37(5). 19–301. 1 indexed citations
18.
Abe, Takashige, Ryuji Matsumoto, Takahiro Osawa, et al.. (2014). Outcome of Regional Lymphadenectomy in Accordance with Primary Tumor Location on Laparoscopic Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract: A Prospective Study. Journal of Endourology. 29(3). 304–309. 16 indexed citations
20.
Harada, Hiroshi, Masaki Togashi, Takashige Abe, et al.. (2000). Renal arteriovenous malformation with thrombus in the inferior vena cava. International Journal of Urology. 7(8). 310–312. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026